Literature DB >> 18787561

A signal-switch hypothesis for cross-regulation of cytokine and TLR signalling pathways.

Lionel B Ivashkiv1.   

Abstract

The importance of immunoreceptor tyrosine-based activation motif (ITAM)-coupled receptors in modulating signalling pathways downstream of other types of receptor is well established, but the mechanisms underlying this modulation are not known. Recent data suggest that calcium-dependent signalling downstream of ITAM-coupled receptors regulates the amplitude and functional outcomes of cytokine and TLR signalling. In this Opinion article, I describe a model whereby the intensity of ITAM-dependent signalling and the balance of calcium signals relative to other ITAM-mediated signalling pathways determines whether cellular responses to cytokines and TLR ligands are increased or inhibited. This model describes mechanisms that explain how ITAM-coupled receptors regulate heterologous signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787561      PMCID: PMC2581615          DOI: 10.1038/nri2396

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  60 in total

1.  Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines.

Authors:  L Pricop; P Redecha; J L Teillaud; J Frey; W H Fridman; C Sautès-Fridman; J E Salmon
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

Review 2.  Immune inhibitory receptors.

Authors:  J V Ravetch; L L Lanier
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

Review 3.  RAFTK/Pyk2-mediated cellular signalling.

Authors:  H Avraham; S Y Park; K Schinkmann; S Avraham
Journal:  Cell Signal       Date:  2000-03       Impact factor: 4.315

Review 4.  Fcgamma receptors as regulators of immune responses.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

5.  Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways.

Authors:  S T Ahmed; L B Ivashkiv
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

6.  CD16 promotes Escherichia coli sepsis through an FcR gamma inhibitory pathway that prevents phagocytosis and facilitates inflammation.

Authors:  Fabiano Pinheiro da Silva; Meryem Aloulou; David Skurnik; Marc Benhamou; Antoine Andremont; Irineu T Velasco; Murilo Chiamolera; J Sjef Verbeek; Pierre Launay; Renato C Monteiro
Journal:  Nat Med       Date:  2007-10-14       Impact factor: 53.440

7.  Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcRgamma.

Authors:  Ching-Liang Chu; Yen-Ling Yu; Kuan-Yin Shen; Clifford A Lowell; Lewis L Lanier; Jessica A Hamerman
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

8.  'Tuning' of type I interferon-induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages.

Authors:  Lu Wang; Ioannis Tassiulas; Kyung-Hyun Park-Min; Alicia C Reid; Hava Gil-Henn; Joseph Schlessinger; Roland Baron; J Jillian Zhang; Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2007-12-16       Impact factor: 25.606

9.  Transient inhibition of interleukin 4 signaling by T cell receptor ligation.

Authors:  J Zhu; H Huang; L Guo; T Stonehouse; C J Watson; J Hu-Li; W E Paul
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

10.  Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion.

Authors:  I H Lee; W P Li; K B Hisert; L B Ivashkiv
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

View more
  48 in total

Review 1.  Interleukin-33 biology with potential insights into human diseases.

Authors:  Gaby Palmer; Cem Gabay
Journal:  Nat Rev Rheumatol       Date:  2011-04-26       Impact factor: 20.543

Review 2.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

3.  The anti-inflammatory glycoprotein, CD200, restores neurogenesis and enhances amyloid phagocytosis in a mouse model of Alzheimer's disease.

Authors:  Megan M Varnum; Tomomi Kiyota; Kaitlin L Ingraham; Seiko Ikezu; Tsuneya Ikezu
Journal:  Neurobiol Aging       Date:  2015-08-01       Impact factor: 4.673

Review 4.  Integration of cytokine and heterologous receptor signaling pathways.

Authors:  Jelena S Bezbradica; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

Review 5.  Modulation of immune responses through direct activation of Toll-like receptors to T cells.

Authors:  G Liu; L Zhang; Y Zhao
Journal:  Clin Exp Immunol       Date:  2010-01-29       Impact factor: 4.330

6.  Involvement of the HCK and FGR src-family kinases in FCRL4-mediated immune regulation.

Authors:  Yanling Liu; Ksenia Bezverbnaya; Tiantian Zhao; Marion J Parsons; Mengyao Shi; Bebhinn Treanor; Götz R A Ehrhardt
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

7.  ITAM-coupled receptors inhibit IFNAR signaling and alter macrophage responses to TLR4 and Listeria monocytogenes.

Authors:  Linda Huynh; Lu Wang; Chao Shi; Kyung-Hyun Park-Min; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2012-02-24       Impact factor: 5.422

Review 8.  Cross-regulation of signaling by ITAM-associated receptors.

Authors:  Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

9.  Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease.

Authors:  Naoki Nakagawa; Luke Barron; Ivan G Gomez; Bryce G Johnson; Allie M Roach; Sei Kameoka; Richard M Jack; Mark L Lupher; Sina A Gharib; Jeremy S Duffield
Journal:  JCI Insight       Date:  2016-12-08

Review 10.  Genetics of Lupus Nephritis: Clinical Implications.

Authors:  Melissa E Munroe; Judith A James
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.